Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerri J Kinghorn

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Rare Diseases (Austin, Tex.)|May 4, 2016
Mitochondrial dysfunction and defects in lipid homeostasis as therapeutic targets in neurodegeneration with brain iron accumulationKerri J Kinghorn, Jorge Iván Castillo-Quan
Gaceta Medica De Mexico|November 27, 2013
[Molecular gerontology: towards healthy aging]Jorge Iván Castillo-Quan, Kerri J Kinghorn
Advances in Genetics|August 23, 2015
Genetics and pharmacology of longevity: the road to therapeutics for healthy agingJorge Iván Castillo-Quan, Kerri J Kinghorn, Ivana Bjedov
Autophagy Reports|May 21, 2025
Autophagic dysregulation triggers innate immune activation in glucocerebrosidase deficiencyMagda L Atilano, Alexander J Hull, Kerri J Kinghorn
Neural Regeneration Research|January 22, 2020
Shifting equilibriums in Alzheimer's disease: the complex roles of microglia in neuroinflammation, neuronal survival and neurogenesisSophie C Gray, Kerri J Kinghorn, Nathaniel S Woodling
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|February 18, 2024
Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discoveryAlexander Hull, Magda L Atilano, Laith Gergi, et al.
Neural Regeneration Research|May 5, 2017
The emerging role of autophagic-lysosomal dysfunction in Gaucher disease and Parkinson's diseaseKerri J Kinghorn, Amir M Asghari, Jorge Iván Castillo-Quan
Current Opinion in Pharmacology|September 8, 2004
Therapeutic targets from a Drosophila model of Alzheimer's diseaseDamian C Crowther, Kerri J Kinghorn, Richard Page, et al.
Human Molecular Genetics|October 15, 2024
Ceramide lowering rescues respiratory defects in a Drosophila model of acid sphingomyelinase deficiencyAlexander J Hull, Magda L Atilano, Jenny Hallqvist, et al.
European Journal of Human Genetics : EJHG|December 25, 2003
Practical genetics: alpha-1-antitrypsin deficiency and the serpinopathiesDamian C Crowther, Didier Belorgey, Elena Miranda, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Rare Diseases (Austin, Tex.)|May 4, 2016
Mitochondrial dysfunction and defects in lipid homeostasis as therapeutic targets in neurodegeneration with brain iron accumulationKerri J Kinghorn, Jorge Iván Castillo-Quan
Gaceta Medica De Mexico|November 27, 2013
[Molecular gerontology: towards healthy aging]Jorge Iván Castillo-Quan, Kerri J Kinghorn
Advances in Genetics|August 23, 2015
Genetics and pharmacology of longevity: the road to therapeutics for healthy agingJorge Iván Castillo-Quan, Kerri J Kinghorn, Ivana Bjedov
Autophagy Reports|May 21, 2025
Autophagic dysregulation triggers innate immune activation in glucocerebrosidase deficiencyMagda L Atilano, Alexander J Hull, Kerri J Kinghorn
Neural Regeneration Research|January 22, 2020
Shifting equilibriums in Alzheimer's disease: the complex roles of microglia in neuroinflammation, neuronal survival and neurogenesisSophie C Gray, Kerri J Kinghorn, Nathaniel S Woodling
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|February 18, 2024
Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discoveryAlexander Hull, Magda L Atilano, Laith Gergi, et al.
Neural Regeneration Research|May 5, 2017
The emerging role of autophagic-lysosomal dysfunction in Gaucher disease and Parkinson's diseaseKerri J Kinghorn, Amir M Asghari, Jorge Iván Castillo-Quan
Current Opinion in Pharmacology|September 8, 2004
Therapeutic targets from a Drosophila model of Alzheimer's diseaseDamian C Crowther, Kerri J Kinghorn, Richard Page, et al.
Human Molecular Genetics|October 15, 2024
Ceramide lowering rescues respiratory defects in a Drosophila model of acid sphingomyelinase deficiencyAlexander J Hull, Magda L Atilano, Jenny Hallqvist, et al.
European Journal of Human Genetics : EJHG|December 25, 2003
Practical genetics: alpha-1-antitrypsin deficiency and the serpinopathiesDamian C Crowther, Didier Belorgey, Elena Miranda, et al.
Pageof 3